Methods and compositions for improved articular surgery using collagen
First Claim
1. A composition for the treatment of post-surgical articular or incisional pain or discomfort consisting essentially of an aqueous dispersion of insoluble non-crosslinked type I fibrillar atelopeptide collagen and an anesthetic;
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
1 to about 10;
1, and wherein the melting temperature of the composition is from about 42°
C. to about 46°
C.
12 Assignments
0 Petitions
Accused Products
Abstract
The invention provides methods for treating post-surgical articular or incisional pain and/or discomfort in a patient. The invention further provides improved surgical methods and controlled release formulations for treating an articular injury of a joint in a patient, in which a collagen formulation is used in conjunction with a surgical procedure to treat the articular injury or the side effects of the surgical procedure. Collagen formulations of the invention and their use, in addition to the surgical procedure, may provide at least one or more of the following benefits: reduced patient pain, shortened recovery time and/or improved joint condition (including treatment of the underlying articular injury). Moreover, the methods and compositions of the invention can be used in conjunction with essentially any surgical procedure used to treat an articular injury. The invention further provides compositions and methods for treating post-surgical articular or incisional pain in a patient as well as a catheter for use in the methods of the invention.
184 Citations
98 Claims
-
1. A composition for the treatment of post-surgical articular or incisional pain or discomfort consisting essentially of an aqueous dispersion of insoluble non-crosslinked type I fibrillar atelopeptide collagen and an anesthetic;
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
1 to about 10;
1, and wherein the melting temperature of the composition is from about 42°
C. to about 46°
C. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
-
20. A composition for the treatment of post-surgical articular or incisional pain or discomfort consisting essentially of an aqueous dispersion of insoluble non-crosslinked type I fibrillar atelopeptide collagen and bupivacaine;
- wherein the composition is formulated to release an effective amount of the bupivacaine from the collagen for at least 48 hours, wherein the collagen and bupivacaine are in a ratio of from about 0.5;
1 to about 10;
1, and wherein the melting temperature of the composition is from about 42°
C. to about 46°
C. - View Dependent Claims (21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)
- wherein the composition is formulated to release an effective amount of the bupivacaine from the collagen for at least 48 hours, wherein the collagen and bupivacaine are in a ratio of from about 0.5;
-
36. A method for the treatment of post-surgical pain or discomfort in a joint(s) comprising the step of intra-articularly administering to a joint(s) in a patient a composition consisting essentially of an aqueous dispersion of insoluble non-crosslinked Type I fibrillar atelopeptide collagen and an anesthetic;
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
1 to about 10;
1, wherein the melting temperature of the composition is from about 42°
C. to about 46°
C., and wherein the composition is administered before, during or after a surgical procedure. - View Dependent Claims (37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61)
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
-
62. A method for the treatment of post-surgical pain or discomfort associated with one or more incisions comprising the step administering to a patient'"'"'s incision(s) a composition consisting essentially of an aqueous dispersion of insoluble non-crosslinked type I fibrillar atelopeptide collagen and an anesthetic;
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
1 to about 10;
1, wherein the melting temperature of the composition is from about 42°
C. to about 46°
C., and wherein the composition is administered before, during or after a surgical procedure. - View Dependent Claims (63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)
- wherein the composition is formulated to release an effective amount of the anesthetic from the collagen for at least 48 hours, wherein the collagen and the anesthetic are in a ratio of from about 0.5;
-
74. A method for the treatment of post-surgical pain or discomfort in a joint(s) comprising the step of intra-articularly administering to a joint(s) in a patient a composition consisting essentially of an aqueous dispersion of insoluble non-crosslinked type I fibrillar atelopeptide collagen and bupivacaine, wherein the composition is formulated to release an effective amount of the bupivacaine from the collagen for at least 48 hours, wherein the collagen and bupivacaine are in a ratio of from about 0.5:
- 1 to about 10;
1, wherein the melting temperature of the composition is from about 42°
C. to about 46°
C., and wherein the composition is administered before, during or after a surgical procedure. - View Dependent Claims (75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98)
- 1 to about 10;
Specification